Beta Bionics (NASDAQ: BBNX) net income
Beta Bionics reported a net loss of $73.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $54.8m. Earnings per share were −$1.81.
Beta Bionics's best year of the last 3 was fiscal 2023. It reported a loss in 3 of those 3 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$73.2m | — | −73.0% | −$1.81 |
| 2024 | −$54.8m | — | −84.1% | −$8.60 |
| 2023 | −$44.1m | — | −367.6% | −$8.31 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Beta Bionics net income compared with its sector
By net income for its latest fiscal year, Beta Bionics ranks 300th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Beta Bionics, −73.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 298th | AdaptHealth | −$70.8m | −2.2% |
| 299th | Pulse Biosciences | −$72.8m | −20,794.6% |
| 300th | Beta Bionics | −$73.2m | −73.0% |
| 301st | Tectonic Therapeutic | −$74.2m | — |
| 302nd | Foghorn Therapeutics | −$74.3m | −240.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Beta Bionics
- How much did Beta Bionics earn in fiscal 2025?
- Beta Bionics reported a net loss of $73.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $54.8m.
- What are the earnings per share of Beta Bionics?
- They were −$1.81 in fiscal 2025, compared with −$8.60 in fiscal 2024.
- Where does Beta Bionics rank in its sector by net income?
- It ranks 300th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Beta Bionics come from?
- From the annual report (Form 10-K) that Beta Bionics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Beta Bionics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Beta Bionics: the Beta Bionics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.